Ddl Cannabis: il Parlamento ha bocciato l’autoproduzione per soli 16 voti

191 voti a favore, 207 contro. Con questo scarto risicato è stato respinto dal Parlamento l’emendamento che avrebbe consentito l’autoproduzione di cannabis dietro ricetta medica. È successo ieri sera durante la votazione sulla proposta di legge per la cannabis terapeutica presentata da Anna Margherita Miotto (Pd).

in Cannabis / High times  19 ottobre 2017

Le opposizioni di Movimento 5 Stelle e Sinistra Italiana avevano presentato due emendamenti al testo di legge in discussione per consentire l’autoproduzione per i malati sia in forma personale che associativa, e avevano ottenuto che i due voti si tenessero a scrutinio segreto, sperando in questo modo che alcuni deputati del Pd disobbedissero alle direttive di partito, votando a favore grazie al segreto dell’urna.

La manovra non è riuscita per poco, influenzata anche dalle molte assenze tra i banchi. Gli emendamenti sono stati entrambi bocciati, rispettivamente con 189 sì e 210 no il primo e 191 sì e 207 no il secondo. Impossibile non sottolineare come, se tutti gli appartenenti dell’intergruppo parlamentare per la legalizzazione (forte di 220 membri) dopo aver per mesi sbandierato il loro favore alla riforma delle leggi proibizioniste, fossero stati almeno presenti ieri in aula gli emendamenti sarebbero passati.

Il Parlamento ha invece approvato la prima lettura della proposta di legge Miotto, una proposta nata nelle commissioni per volontà del governo, in contrapposizione alla proposta di legalizzazione, e che non comporterà nessun reale miglioramento, neppure per i malati che hanno diritto alle cure a base di cannabis. Una proposta “foglia di fico”, da approvare solo per poter dire ai media di aver fatto qualcosa in questo senso.

A votare con il governo, almeno nelle votazioni palesi, sono stati insieme Pd Forza e Italia, inclusi anche i parlamentari democratici che in passato avevano aderito all’intergruppo della legalizzazione. Tra questi anche Roberto Giachetti, ovvero colui che era stato primo firmatario del ddl per la legalizzazione, che ha spiegato di averlo fatto per “disciplina di partito”.

 

 

 

 

http://www.dolcevitaonline.it/ddl-cannabis-il-parlamento-ha-bocciato-lautoproduzione-per-soli-16-voti/

Annunci

Jeff Sessions calls for “more competition” among medical marijuana growers for research

AG Jeff Sessions questioned by Senate committee about reports of feud between DEA and DOJ over planned expansion of marijuana cultivation for research purposes

 

By Polly Washburn, The Cannabist Staff

In testimony before the Senate Judiciary Committee Wednesday, U.S. Attorney General Jeff Sessions said there should be “more competition” among growers who supply marijuana for federally approved research, though he said he thought the current applicant pool of 26 was too many.

His statement came in response to a question from Sen. Orrin Hatch, a Republican from Utah. Hatch referred to legislation he recently co-sponsored with Sen. Brian Schatz, D-Hawaii, known as the MEDS Act. “I believe that scientists need to study the potential benefits and risks of marijuana,” said Hatch, though clarifying that “I remain opposed to the broad legalization of marijuana.”

Hatch said he was “very concerned” with reports that the Drug Enforcement Administration (DEA) and the Justice Department (DOJ) “are at odds” over granting additional applications for cultivating marijuana for research purposes. In August, DEA officials said they had been waiting for the Justice Department’s sign-off to move forward on 25 applications, and expressed frustration that the Justice Department had not been willing to provide that sign-off.

“Can you clarify the position of the Justice Department regarding these applications?” Hatch asked the head of the DOJ.

Sessions responded:

“We have a marijuana research system working now. There is one supplier of the marijuana for that research. People have asked that there be multiple sources of the marijuana for medicinal research and have asked that it be approved. I believe there are now 26 applications for approval of suppliers who would provide marijuana for medicinal research. Each one of those has to be supervised by the DEA, and I have raised questions about how many and let’s be sure we’re doing this in the right way because it costs a lot of money to supervise these [indecipherable]. I think it would be healthy to have some more competition in the supply but I’m sure we don’t need 26 new suppliers.”

This statement comes after  months of concern that Sessions has plans to crack down on both medical marijuanafter months of concern that Sessions has plans to crack down on both medical marijuana and adult-use marijuana, and after his own request to Congress in May of this year to be allowed to prosecute medical marijuana providers.

In August 2016, the DEA said that private companies would be able to apply to grow medical marijuana to develop cannabis-based medicines with federal approval. That announcement was coupled with the DEA’s denial of petitions to reschedule marijuana in the federal Controlled Substances Act. The Schedule I status of cannabis is widely considered a hindrance to further study of the substance.

Sessions was representing the Justice Department during an oversight hearing. He has been asked to speak to the Trump administration about DOJ policies on drugs, crime, terrorism, immigration and other topics. The hearing was the Senate Judiciary Committee’s first opportunity to quiz Sessions since his confirmation hearing.

Sessions also discussed the asset forfeiture policy overseen by the DOJ, and touted the department’s new internal watchdog which will monitor the program that allows state and local police to confiscate cash and property from people suspected of committing a crime that violates federal law — even if they haven’t been charged — and then share the proceeds with federal agencies.

 

 

http://www.thecannabist.co/2017/10/18/jeff-sessions-medical-marijuana-federal-research/90347/

RECREATIONAL MARIJUANA NOW LEGAL IN MAINE – HERE’S WHAT YOU NEED TO KNOW

MAINE JOINS SEVEN OTHER STATES AND THE DISTRICT OF COLUMBIA THAT HAVE LEGALIZED MARIJUANA FOR RECREATIONAL USE, DESPITE FEDERAL PROHIBITIONS ON THE DRUG.

Ricreational marijuana now legal in Maine

Here’s what you need to know. You have to be 21 or older to possess up to 2.5 ounces, you can’t use pot in public and you can’t buy it – but you can grow your own.

Q: When can I start using?

A: Marijuana becomes legal Jan. 30, but it is not yet legal for marijuana to be sold.

Q: Can anyone use marijuana legally?

A: No. The law says you have to be 21 years or older.

Q: Can I use as much as I want?

A: No. The law allows an individual to possess as much as 2.5 ounces of marijuana. We’re told you can roll about 60 marijuana cigarettes, or joints, with each ounce. You can also give a friend up to 2.5 ounces as long as you don’t take anything in return.

Q: Can I smoke it anywhere?

A: No. The law prohibits using marijuana in public, whether you smoke it or eat it. You will have two options – smoking in private, such as in your home, or smoking in a state-licensed marijuana social club. You could be fined up to $100 for using marijuana in public.

Q: Wait, a marijuana social club?

A: The new law allows for state-licensed clubs where customers can use marijuana in a social setting. Proponents say it will provide a place for tourists and others to use the drug legally, an issue that has presented problems in other states.

Q: When can I go to a marijuana store or social club in Maine?

A: Not until at least February 2018. Lawmakers have implemented a moratorium on retail sales to allow time to set up a licensing and regulatory framework.

Q: Will there be stores everywhere?

A: Not necessarily. Maine communities can restrict the locations of the businesses or even ban them outright. Some communities are adopting temporary bans to allow time to consider zoning and other rules, and others are implementing permanent bans to become “dry towns.”

Q: Can’t I just buy it from a medical marijuana dispensary or caregiver?

A: No. State-licensed dispensaries and caregivers are only allowed to sell cannabis products to patients who have received a certification from their doctor.

Q: Can I just grow it myself?

A: Yes. An individual is allowed to have six mature plants, 12 immature plants and an unlimited number of seedlings at any given time. You can’t grow it where it is visible to others and must prevent access by anyone under 21. Each plant has to be labeled with a tag that includes your name and your Maine driver’s license or identification number.

Q: What about workplace drug testing?

A: State officials have said the referendum language is unclear about workplace drug testing, while proponents have said employers will still be able to use drug tests to screen job applicants and existing employees. Employers can forbid employees from coming to work under the influence of marijuana, but standard drug tests do not prove someone is impaired at the time of the test and positive results could reflect marijuana use that occurred weeks before the test was done.

Q: What about smoking pot and driving?

A: It will remain illegal – and dangerous – to drive while intoxicated, whether because of alcohol use or marijuana use. There is no existing test similar to an alcohol Breathalyzer to determine intoxication by marijuana, so police officers will use field sobriety tests and other evidence to determine whether someone has used marijuana before getting behind the wheel.

Q: Can I buy a gun if I use marijuana?

A: This is because marijuana is illegal on the federal level.

From: The Portland Herald

https://medicalmarijuana411.com/recreational-marijuana-now-legal-maine-heres-need-know/?utm_source=newsletter101217&utm_medium=email&utm_campaign=dailydose&utm_content=readmore

Crowdfunding Site Cancels Aid to California Wildfire Victims—Because Cannabis

With the most devastating wildfire in California history laying waste to its members’ homes and livelihoods, the California Growers Association responded in the way most crises are handled in 2017: crowdfunding.

As of Tuesday morning, 41 people have perished in the fires, which have burned more than 101,000 acres and destroyed 6,700 homes and businesses at an estimated cost of more than $3 billion. Multiple fires are still burning in Mendocino, Napa, and Sonoma counties—the very heart of California’s wine and cannabis region—and 88 people are still missing in Sonoma County alone, the Santa Rosa Press-Democrat reported.

Allen began receiving messages from would-be donors. They’d had their donations canceled and their monies returned.

The California Growers Association, the main lobby representing cannabis growers in Sacramento, estimates that as many as 300 marijuana farms have been affected in some way by the deadly fires still burning near Santa Rosa, about 60 miles north of San Francisco. Some have seen entire crops tainted with toxic smoke and ash, while others have lost both their harvests and their homes to the flames.

The fires came at the worst imaginable time: at the height of the fall harvest, in a year when many growers had exhausted their savings or taken on investment to obtain costly county permits ahead of statewide legalization. And unlike other farmers in the region, cannabis growers generally don’t qualify for crop insurance.

 

 

 

 

https://www.leafly.com/news/politics/crowdfunding-site-cancels-aid-to-california-wildfire-victims-because-cannabis?utm_campaign=Roost&utm_source=Roost&utm_medium=push

Recreational marijuana is saving lives in Colorado, study suggests

Opioid deaths fall following the legalization of recreational marijuana sales in the state

By Christopher Ingraham, The Washington Post

Marijuana legalization in Colorado led to a “reversal” of opiate overdose deaths in that state, according to new research published in the American Journal of Public Health.

“After Colorado’s legalization of recreational cannabis sale and use, opioid-related deaths decreased more than 6% in the following 2 years,” write authors Melvin D. Livingston, Tracey E. Barnett, Chris Delcher and Alexander C. Wagenaar.

The authors stress that their results are preliminary, given that their study encompasses only two years of data after the state’s first recreational marijuana shops opened in 2014.

While numerous studies have shown an association between medical marijuana legalization and opioid overdose deaths, this report is one of the first to look at the impact of recreational marijuana laws on opioid deaths.

Marijuana is often highly effective at treating the same types of chronic pain that patients are often prescribed opiates for. Given the choice between marijuana and opiates, many patients appear to be opting for the former.

From a public health standpoint, this is a positive development, considering that relative to opiates, marijuana carries essentially zero risk of fatal overdose.

Now, the study in the American Journal of Public Health suggests that similar findings hold true for recreational marijuana legalization. The authors examined trends in monthly opiate overdose fatalities in Colorado before and after the state’s recreational marijuana market opened in 2014. They attempted to isolate the effect of recreational, rather than medical, marijuana by comparing Colorado to Nevada, which allowed medical but not recreational marijuana during that period.

They also attempted to correct for a change in Colorado’s prescription-drug-monitoring program that happened during the study period. That change required all opioid prescribers to register with, but not necessarily use, the program in 2014.

Overall, after controlling for both medical marijuana and the prescription-drug-monitoring change, the study found that after Colorado implemented its recreational marijuana law, opioid deaths fell by 6.5 percent in the following two years.

The authors say policymakers will want to keep a close eye on the numbers in the coming years to see whether the trend continues. They’d also like to see whether their results are replicated in other states that recently approved recreational marijuana, such as Washington and Oregon.

They note, also, that while legal marijuana may reduce opioid deaths it could also be increasing fatalities elsewhere — on Colorado’s roads, for instance.

Still, the study adds more evidence to the body of research suggesting that increasing marijuana availability could help reduce the toll of America’s opiate epidemic, which claims tens of thousands of lives each year.

 

 

 

 

http://www.thecannabist.co/2017/10/16/colorado-opioid-deaths-marijuana-legalization/90145/

 

Quando non si pagano visite, esami e farmaci: le esenzioni ticket per invalidità

MetropoliZ blog

ticket-esenzione-disabiliLe percentuali di invalidità per cui si è esenti dal pagamento del ticket per le prestazioni sanitarie e i casi di esenzione dal pagamento del ticket per i medicinali

Se si è stati riconosciuti invalidi civili si può aver diritto all’esenzione del ticket per alcune o tuttele prestazioni di specialistica ambulatoriale che vengono erogate dal Servizio Sanitario Nazionale. Ricordiamo che il ticket è una quota che il cittadino è tenuto  a pagare a fronte di alcune prestazioni comprese nei Livelli Essenziali di assistenza (Lea): nel coso della specialistica, parliamo ad esempio di visite, esami strumentali ed ed esami di laboratorio.
L’esenzione dal ticket può spettare anche in  anche in particolari condizioni legate al reddito, alla condizione sociale, o in altri casi particolari. Nel caso di riconoscimento di invalidità civile, l’esenzione non è legata al reddito.

View original post 693 altre parole

A Cannabis ‘Protest’ That Was Well Judged.

Peter Reynolds

This was the best ‘protest’ I have seen. The characterisation of it as a ‘cannabis tea party’ was clever and combining it with Paul Flynn’s 10 minute rule bill was a smart move.

It was good that three MPs actually attended and the press coverage was extensive and largely positive. This is a welcome change from the disastrous demos and protests of the past which have undoubtedly hindered progress.

So while I’m not exactly eating it, I take my hat off to the organisers for a good job, well done.

The most promising news is that Andrea Leadsom, Conservative Leader of the House, has personally endorsed Paul Flynn’s bill which is real chink of light. This government, desperate to recover some credibility with younger and progressive voters, if it had any sense, would see this as a big opportunity. If the government was to choose to support the bill it…

View original post 17 altre parole